EMAIL THIS PAGE TO A FRIEND

Journal of pharmaceutical sciences

Antihyperlipidemic activity of amine cyanoboranes, amine carboxyboranes, and related compounds.


PMID 6115048

Abstract

A series of amine cyanoboranes and amine carboxyboranes were observed to be antihyperlipidemic agents in mice; i.e., they lowered serum cholesterol and triglyceride levels significantly. These compounds appeared to inhibit lipid synthesis in the early stages. The ability to lower serum cholesterol levels appeared to correlate with the suppression of the regulatory enzyme of cholesterol synthesis, beta-hydroxy-beta-methylglutaryl-CoA reductase activity. The reduction of serum triglycerides correlated with ability of the borane compound to suppress liver fatty acid synthetase activity.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A1181
Ammonia–boranecarboxylic acid
CH6BNO2
D3662
Dimethylamine-boranecarboxylic acid
C3H10BNO2